Trientine Dihydrochloride
Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease
- January 16, 2026
- 0
- Category:
- Tags: healthcareIkris Pharma NetworkMr. Praveen SikriTrientine DihydrochlorideTriokris™
Noida, India — 15 January, 2026 - Ikris Pharma Network announced the availability of Triokris™ (Trientine Dihydrochloride 250 mg Capsules), a therapeutic option for patients diagnosed with Wilson's Disease, a...
Read moreRecent Posts
SARGAD and Government of Telangana Sign MoU to Invest $100 Million USD in Aerospace & Defence Manufacturing Ecosystem
- January 22, 2026
- 0
Davos [Switzerland],
